Jynarque
Ended Awarded Last action
- Contract number
- 36C26124N0640
- Awardee
-
Otsuka America Pharmaceutical Inc. UEI QKABLBMA8FT9
- Awarding agency
-
Veterans Integrated Service Network 21
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $12,581
Award facts
- Contract value 100% obligated
- $12,580.72 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Rockville, MD 20850, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$12,244 | |
| Original award | $24,824 |
About this award
On May 7, 2024, the Department of Veterans Affairs (VA), through Veterans Integrated Service Network 21, awarded a delivery order valued at $12,580.72 to Otsuka America Pharmaceutical Inc. for Jynarque (tolvaptan), a specialty pharmaceutical used to treat autosomal dominant polycystic kidney disease and hyponatremia. This firm fixed-price delivery order, with an ultimate completion date of July 8, 2024, was issued without a set-aside designation and will be performed in Potomac, Maryland. The award falls under the parent Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), reflecting the VA's established procurement vehicle for pharmaceutical products.
This delivery order is part of Otsuka America Pharmaceutical Inc.'s broader relationship with the VA, which includes a substantial $83.3 million Blanket Purchase Agreement for Jynarque through the National Acquisition Center with completion through March 26, 2026, as well as a $396 million Federal Supply Schedule contract for pharmaceuticals and related products. The delivery order supports the VA's mission to provide specialized pharmaceutical treatments to veterans across multiple Integrated Service Networks, leveraging established indefinite delivery vehicles to streamline procurement of critical medications for the veteran population.
Quick answers
Who was awarded contract 36C26124N0640?
36C26124N0640 was awarded to Otsuka America Pharmaceutical Inc. by Veterans Integrated Service Network 21 (Veterans Health Administration) on May 7, 2024.
How much is contract 36C26124N0640 worth?
The government has obligated $12,581 on 36C26124N0640.
Is contract 36C26124N0640 an order under another contract?
Yes. 36C26124N0640 is a delivery order under 36F79720D0099, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26124N0640 competed?
The extent of competition for 36C26124N0640 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award